STOCK TITAN

[4] – Gladden Brian T (CIK 0001435432)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

DENTSPLY SIRONA (XRAY) director Brian T. Gladden reported an automatic credit of 286.094 additional RSUs on 10/10/2025 at $0, reflecting dividend equivalents on prior RSU awards. Each RSU converts 1:1 into common stock and follows the same vesting schedule as the underlying awards. After this entry, his beneficial ownership stood at 28,726.563 shares, held directly.

DENTSPLY SIRONA (XRAY) il direttore Brian T. Gladden ha riportato un accredito automatico di 286.094 RSU aggiuntive il 10/10/2025 a $0, riflettendo equivalenti di dividendi su precedenti premi RSU. Ogni RSU si converte 1:1 in azioni ordinarie e segue lo stesso calendario di vesting degli assegni sottostanti. Dopo questa voce, la sua proprietà beneficiaria ammontava a 28.726,563 azioni, detenute direttamente.

DENTSPLY SIRONA (XRAY) el director Brian T. Gladden informó un crédito automático de 286.094 RSU adicionales el 10/10/2025 a $0, reflejando equivalentes de dividendos sobre premios RSU anteriores. Cada RSU se convierte 1:1 en acciones comunes y sigue el mismo calendario de vesting que las adjudicaciones subyacentes. Después de esta entrada, su propiedad beneficiosa se situó en 28.726.563 acciones, poseídas directamente.

DENTSPLY SIRONA (XRAY) 이사인 Brian T. Gladden은 2025년 10월 10일에 0달러로 286.094주의 추가 RSU를 자동으로 크레딧했다고 보고했습니다. 각 RSU는 보통주로 1:1 변환되며 기초 보상과 동일한 vesting 일정이 적용됩니다. 이 항목 이후, 그의 실질 보유 주식은 직접 보유한 28,726.563주로 남아 있습니다.

DENTSPLY SIRONA (XRAY) le directeur Brian T. Gladden a enregistré un crédit automatique de 286.094 RSU supplémentaires le 10/10/2025 à 0 $, reflétant des équivalents de dividendes sur les RSU antérieures. Chaque RSU se convertit 1:1 en actions ordinaires et suit le même calendrier d’acquisition que les attributions sous-jacentes. Après cette entrée, sa propriété bénéficiaire s’élevait à 28 726,563 actions, détenues directement.

DENTSPLY SIRONA (XRAY) Direktor Brian T. Gladden meldete am 10.10.2025 eine automatische Gutschrift von 286.094 zusätzlichen RSUs zu 0 $, die Dividendenäquivalente auf vorherige RSU-Zuwendungen widerspiegelt. Jede RSU wandelt sich 1:1 in Stammaktien um und folgt dem gleichen Vesting-Zeitplan wie die zugrunde liegenden Zuwendungen. Nach diesem Eintrag betrug sein wirtschaftliches Eigentum 28.726,563 Aktien, direkt gehalten.

دنتس بلاي سيرونا (XRAY) مديرها بريان ت. غلادن أبلغ عن ائتمان تلقائي قدره 286.094 RSU إضافية في 10/10/2025 بسعر 0 دولار، يعكس ما يعادل توزيعات الأرباح على جوائز RSU السابقة. كل RSU يتحول 1:1 إلى أسهم عادية ويتبع نفس جدول الاستحقاق كالمكافآت الأساسية. بعد هذا الإدخال، بلغ امتلاكه الفعلي 28,726,563 سهمًا، مملوكة بشكل مباشر.

DENTSPLY SIRONA (XRAY) 董事 Brian T. Gladden 于 2025/10/10 报告了自动记入额外的 286.094 股 RSU,价格为 0 美元,反映先前 RSU 授予的股息等值。每股 RSU 1:1 转换为普通股,并遵循与基础授予相同的归属期程。在此条目之后,他的实际控制权为直接持有的 28,726.563 股。

Positive
  • None.
Negative
  • None.

DENTSPLY SIRONA (XRAY) il direttore Brian T. Gladden ha riportato un accredito automatico di 286.094 RSU aggiuntive il 10/10/2025 a $0, riflettendo equivalenti di dividendi su precedenti premi RSU. Ogni RSU si converte 1:1 in azioni ordinarie e segue lo stesso calendario di vesting degli assegni sottostanti. Dopo questa voce, la sua proprietà beneficiaria ammontava a 28.726,563 azioni, detenute direttamente.

DENTSPLY SIRONA (XRAY) el director Brian T. Gladden informó un crédito automático de 286.094 RSU adicionales el 10/10/2025 a $0, reflejando equivalentes de dividendos sobre premios RSU anteriores. Cada RSU se convierte 1:1 en acciones comunes y sigue el mismo calendario de vesting que las adjudicaciones subyacentes. Después de esta entrada, su propiedad beneficiosa se situó en 28.726.563 acciones, poseídas directamente.

DENTSPLY SIRONA (XRAY) 이사인 Brian T. Gladden은 2025년 10월 10일에 0달러로 286.094주의 추가 RSU를 자동으로 크레딧했다고 보고했습니다. 각 RSU는 보통주로 1:1 변환되며 기초 보상과 동일한 vesting 일정이 적용됩니다. 이 항목 이후, 그의 실질 보유 주식은 직접 보유한 28,726.563주로 남아 있습니다.

DENTSPLY SIRONA (XRAY) le directeur Brian T. Gladden a enregistré un crédit automatique de 286.094 RSU supplémentaires le 10/10/2025 à 0 $, reflétant des équivalents de dividendes sur les RSU antérieures. Chaque RSU se convertit 1:1 en actions ordinaires et suit le même calendrier d’acquisition que les attributions sous-jacentes. Après cette entrée, sa propriété bénéficiaire s’élevait à 28 726,563 actions, détenues directement.

DENTSPLY SIRONA (XRAY) Direktor Brian T. Gladden meldete am 10.10.2025 eine automatische Gutschrift von 286.094 zusätzlichen RSUs zu 0 $, die Dividendenäquivalente auf vorherige RSU-Zuwendungen widerspiegelt. Jede RSU wandelt sich 1:1 in Stammaktien um und folgt dem gleichen Vesting-Zeitplan wie die zugrunde liegenden Zuwendungen. Nach diesem Eintrag betrug sein wirtschaftliches Eigentum 28.726,563 Aktien, direkt gehalten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Gladden Brian T

(Last) (First) (Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NC 28277

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/10/2025 A 286.094(1) A $0 28,726.563 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
/s/ Jessica Nielsen Causey, Attorney-in-Fact for Brian T. Gladden 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Dentsply Sirona Inc

NASDAQ:XRAY

XRAY Rankings

XRAY Latest News

XRAY Latest SEC Filings

XRAY Stock Data

2.52B
198.69M
0.39%
104.2%
3.83%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
CHARLOTTE